Recurrent venous thrombosis during warfarin treatment related to acquired protein S deficiency

Thromb Res. 1992 Jun 15;66(6):729-34. doi: 10.1016/0049-3848(92)90048-f.

Abstract

Failure of warfarin to prevent new thrombotic processes was observed in three patients with very low free protein S concentrations and high C4b-binding protein (C4bBP) concentrations, and in one patient with hereditary protein S deficiency. We suggest that an increase in C4bBP reduces the free Protein S level, and warfarin treatment causes an additional decrease of free protein S. The four patients presented indicate that such reductions are of clinical importance. Heparin seems preferable as an anticoagulant in this situation, as warfarin given alone is ineffective, or may even be harmful. In a group of pancreatic cancer patients with advanced disease, subnormal mean free protein S was found, whereas mean total protein S concentration, and mean C4bBP concentrations were significantly higher (p less than 0.01) than in healthy controls. These findings indicate that an increase in C4bBP may induce free protein S deficiency contributing to the increased thrombotic tendency in this group of patients. The correlation between free protein S and C4bBP was 0.11, (n.s.), between total protein S and C4bBP 0.73 (p less than 0.0001).

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Aged
  • Carrier Proteins / blood*
  • Complement Inactivator Proteins*
  • Female
  • Glycoproteins*
  • Heparin / administration & dosage
  • Humans
  • Male
  • Middle Aged
  • Pancreatic Neoplasms / blood
  • Peptide Fragments / blood*
  • Peptide Fragments / deficiency
  • Protein S Deficiency
  • Ribonuclease, Pancreatic / blood*
  • Ribonuclease, Pancreatic / deficiency
  • Thrombophlebitis / blood*
  • Warfarin / adverse effects*

Substances

  • Carrier Proteins
  • Complement Inactivator Proteins
  • Glycoproteins
  • Peptide Fragments
  • Warfarin
  • Heparin
  • ribonuclease A (21-124)
  • Ribonuclease, Pancreatic